42 North Solutions

42° North Solutions was acquired by Sequoia Biotech Consulting and subsequently integrated into Syner-G following the 2024 Sequoia–Syner-G merger. To stay connected with our team and receive the latest insights and updates, follow us on LinkedIn at Syner-G is a Strategic Development & Delivery Partner™ to biopharma innovators, bringing together integrated scientific, regulatory, technical, and consulting expertise across the development lifecycle. With a global reach of more than 400 professionals across North America, Europe, and APAC, Syner-G collaborates with clients to address the complexity of drug development and commercialization, advancing science to improve patient lives. To learn more, visit synergbiopharma.com.